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Background: Though ergosterol peroxide (EP) derived from Neungyi mushrooms (Sarcodon aspratus) was known
to have cytotoxic, apoptotic, anti-inflammatory and antimycobacterial effects, the underlying molecular mechanism
of EP still remains unclear. Thus, in the present study, the apoptotic mechanism of EP was elucidated in DU 145
prostate cancer cells.
Methods: Cell viability of prostate cancer cells was measured by MTT assay. To see whether EP induces the
apoptosis, FACS, western blot and TUNEL assay were performed. To determine the role of Death receptor (DR)
5 molecules in EP-induced apoptosis in DU 145 prostate cancer cells, the silencing of DR 5 was performed by using
siRNAs.
Results: EP showed significant cytotoxicity against DU 145, PC 3, M2182 prostate cancer cells. Also, EP effectively
increased the sub G1 population and terminal deoxynucleotidyl transferase DUTP nick end labeling (TUNEL) positive
cells in DU 145 prostate cancer cells. Furthermore, western blotting revealed that EP cleaved poly (ADP-ribose)
polymerase (PARP) and caspase 8/3, attenuated the expression of fluorescence loss in photobleaching (FLIP), Bcl-XL
and Bcl-2 as well as activated Bax, Fas-associated death domain (FADD) and DR 5 in a concentration dependent
manner in DU 145 prostate cancer cells. Conversely, caspase 8 inhibitor Z-IETD-FMK blocked the apoptotic ability of
EP to cleave PARP and an increase of sub G1 population in DU 145 prostate cancer cells. Likewise, the silencing of
DR 5 suppressed the cleavages of PARP induced by EP in DU 145 prostate cancer cells.
Conclusion: Overall, our findings suggest that ergosterol peroxide induces apoptosis via activation of death
receptor 5 and caspase 8/3 in DU 145 prostate cancer cells as a cancer chemopreventive agent or dietary factor.
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Prostate cancer is the second most frequently diagnosed
cancer and the sixth leading cause of cancer death in
males worldwide in 2011 [1]. Human prostate cancer
cell lines are established including androgen dependent
cancer LNCap and androgen independent cancers such* Correspondence: sungkim7@khu.ac.kr
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unless otherwise stated.as PC 3, TSU-Prl and DU 145 prostate cancer cells [2].
Though modern therapies such as chemotherapy, radio-
therapy, surgery and castration have contributed to the
treatment and prevention of prostate cancers, prostate can-
cer still remains refractory disease. Thus, recently herbal
medicine [3,4] and phytochemicals [5-8] are attractive as
supplements for combination therapy with cancer pre-
ventive or therapeutic agents targeting apoptosis, angio-
genesis and metastasis.
Apoptosis is the process of programmed cell death (PCD),
generally consisting of intrinsic mitochondrial pathway and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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agents from natural products are attractive by target-
ing apoptosis in several cancers [9-11]. Sarcodon edible
mushroom [12] and its compound ergosterol peroxide
(EP) [13], one of β-D-glucan metabolites, were reported to
have antitumor activity in several cancers. Nonetheless,
the underlying molecular mechanism of EP was not fully
understood in prostate cancer. Thus, in the present study,
the underlying apoptotic mechanism of EP was investi-
gated in DU 145 prostate cancer cells targeting extrinsic
apoptosis via DR 5 signaling using MTT assay, cell cycle
analysis, TUNEL assay, western blotting and inhibitor
study using caspase 8 inhibitor Z-IETD-FMK and siRNA
transfection of DR 5.
Methods
Isolation of ergosterol peroxide
Ergosterol peroxide (EP; Figure 1) was isolated from
Neungyi mushrooms (Sarcodon aspratus) as previously
described with some modifications [12,14]. In brief,
Sarcodon aspratus was extracted with acetone, and then
EP was isolated from the acetone extract by using
column chromatography (Waters, USA), silica gel col-
umn chromatography (Merck, Germany) and reverse-phase
HPLC using a C18 column. Ergosterol was precipi-
tated from the eluate of the silica gel column and finally
EP was identified as 5-alpha, 8-alpha-epidioxy-22eE-
ergosta-6, 22-dien-3beta-ol with chemical structure shown
in Figure 1 by UV spectroscopy, mass spectrometry and
13C- and 1H-NMR. The purity of EP used in this experi-
ment was over 97%.
Cell culture
DU 145, PC 3, M2182 prostate cancer cells, HCT116
colon cancer cells, A549 lung cancer cells, SKOV3 ovary
cancer cells (ATCC® HTB-81™), and RWPE1 normal
benign prostate epithelial cell lines were purchased
from American Type Culture Collection (ATCC, Manassas,
VA, USA). These cells were cultured in RPMI 1640 medium
(Invitrogen, Carlsbad, CA, USA) supplemented with 10%
FBS, 2 mML glutamine, and 100 units/ml antibiotic-
antimycotics.
Cytotoxicity assay
The cell viability was evaluated by using MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
assay (Sigma, St. Louis, MO, USA). DU 145 prostate can-
cer were seeded at 1 × 104 cells/well of 96-well flat bottom
plate and treated with various concentrations of EP (0, 25,
50, 100, 150 and 200 μg/ml) for 72 h. MTT was added to
each well and incubated for 4 h at 37°C. Formazen crystals
were dissolved by addition of dimethyl sulfoxide (DMSO)
solution. The absorbance of each well was determinedusing the microplate reader (Molecular Devices Co.,
Sunnyvale, CA, USA) at 570 nm.
Cell cycle analysis
DU 145 prostate cancer cells treated with EP (25 and
50 μM) for 24 h were fixed in 75% ethanol at -20°C,
resuspended in PBS containing RNase A (1 mg/ml),
and incubated for 1 h at 37°C. Fixed cells were stained
with propidium iodide (50 μg/ml) for 30 min at room
temperature in dark. The DNA contents of the stained
cells were analyzed using CellQuest Software with the
FACSCalibur flow cytometry (Becton Dickinson, Franklin
Lakes, NJ, USA). For the inhibitor study, caspase 8 inhibi-
tor Z-IETD-FMK (20 μM) was treated in DU 145 prostate
cancer cells in the presence or absence of EP for 24 h for
cell cycle analysis.
TUNEL assay
Individual apoptotic cell death was observed using Dead
End TM fluorometric terminal deoxynucleotidyl trans-
ferase DUTP nick end labeling (TUNEL) assay kit
(Sigma, St. Louis, MO, USA) according to the manufac-
turer’s instructions. Briefly, DU 145 prostate cancer cells
treated with EP (25 and 50 μM) were washed with cold
PBS. Cells were seeded after fixing with 4% paraformalde-
hyde for 30 min and washed twice with PBS for 2 min. Re-
suspended cells in permeabilization solution (0.1% Triton
X-100 and 0.1% Sodium citrate) for 4°C overnight were
washed with PBS twice. The cells in 25 ml of TUNEL
assay mixture were incubated for 60 min at 37°C in a hu-
midified atmosphere in the dark. The TUNEL-stained
cells were counter-stained with propidium iodide (Sigma,
St. Louis, MO, USA) and visualized at x200 magnification
by fluorescence microscopy (AXIO observer A1, Zeiss,
Weimar, Germany).
Western blotting
Whole cell lysates of DU 145 were prepared by using lysis
buffer (50 mM Tris-HCl, pH 7.4, 300 mM NaCl, 0.5% Triton
X-100, 5 mM EDTA, 1 mM Na3VO4, 1 mM NaF, 10 μg/ml
aprotinin, 10 μg/ml leupeptin, 10 μg/ml pepstatin, 10 mM
iodoacetamide, 2 mM PMSF). To measure the protein
contents, a Bio-Rad DC protein assay kit II (Bio-Rad,
Hercules, CA, USA) was used. The proteins were sepa-
rated on 10% tris-glycin gels, and electrotransferred
onto a Hybond ECL transfer membrane with transfer
buffer (25 mM Tris, 250 mM glycine, 20% methanol).
The membranes were blocked in 5% nonfat dry milk in
TBS buffer containing 0.1% Tween 20 (TBST) and immu-
noblotted with antibodies of cleaved caspase 3, cleaved cas-
pase 8, procaspase 8, procaspase 9, PARP, Bcl-2, Bcl-XL,
Bax, DR 5, FLIP and FADD (Cell signaling, Beverly, MA,
USA), and β-actin (Sigma Aldrich Co., St. Louis, MO,
USA), and then exposed to horseradish peroxidase (HRP)-
Figure 1 Cytotoxic effect of EP against DU 145 prostate cancer cells. The cells were treated with various concentrations of EP (0, 25, 50, 100,
and 200 μM/mL) for 72 h. Then MTT assay was carried out. (a) Chemical structure of EP. (b) Cytotoxicity of EP in DU 145, PC 3 or M2182 prostate
cancer cells and (c) HCT116 colon cancer cells, A549 lung cancer cells, SKOV3 ovary cancer cells, and (d) RWPE1 (prostate epithelial cells). Data are
presented as means ± S.D of triplicate samples.
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(AbD Serotec, Raleigh, NC, USA). Protein expression
was examined by using enhanced chemiluminescence
(ECL) system (Amersham Pharmacia, Piscataway, NJ,
USA).
siRNA DR 5 transfection
DU 145 prostate cancer cells were transiently transfected
with a validated scrambled control siRNA, or siRNA
specifically for DR 5 (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) by using Interferin™ transfection re-
agent (Polyplus-transfection Inc., New York, NY, USA).
Briefly, the mixture of siRNA and Interferin™ transfec-
tion reagent was incubated for 10 min, added to each
well of the cells (siRNA final concentration = 40 nM)
and incubated at 37°C for 24 h before EP treatment.Statistical analyses
All data were expressed as means ± SD. The statistically
significant differences compared with untreated group
were calculated by Student’s t-test.
Results
Cytotoxic effect of EP against DU 145 prostate cancer cells
EP (Figure 1a) exerted significant cytotoxicity against DU
145 prostate cancer cells compared to non-treated cells. To
evaluate cytotoxic effect of EP, MTT assay was performed.
DU 145 prostate cancer were plated in 96-well plate and
treated with various concentrations (0, 25, 50, 100, and 200
μM/ml) of EP for 72 h. As shown in Figure 1b, the cytotox-
icity of EP was significantly exhibited in concentration
dependent manner in DU 145, PC 3 and M2182 prostate
cancer cells. Additionally, the cytotoxicity of EP was
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cer cells, SKOV3 ovary cancer cells (Figure 1c) and
RWPE1 (normal prostate epithelial cells) (Figure 1d).
MTTassay revealed that EP showed the strong cytotoxic
effect in the prostate cancer cells lines such as DU 145,
PC 3 or M2182 compared to A549 lung cancer cells,Figure 2 The effect of EP inducing apoptosis in DU 145 cells by cell cyc
145 cells. DU 145 prostate cancer were exposed to with EP (25 and 50 μM) fo
temperature in dark. Then flow cytometric analysis was performed. Data are p
assay in DU 145 cells. DU 145 cells treated with EP (25 and 50 μM) were seed
ml of TUNEL assay mixture for 60 min at 37°C in the dark. TUNEL-stained cells
and visualized at x200 magnification by fluorescence microscopy.HCT116 colon cancer cells, SKOV3 ovary cancer cells or
RWPE1 cells.
Apoptotic effect of EP in DU 145 prostate cancer cells
To confirm whether the cytotoxicity of EP was due to
apoptosis, cell cycle analysis and TUNEL assay werele and TUNEL assay. (a) The effect of EP on sub G1 population in DU
r 24 h and stained with propidium iodide (50 μg/ml) for 30 min at room
resented as means ± S.D of triplicate samples. (b) Effect of EP on TUNEL
ed after fixing with 4% paraformaldehyde for 30 min and incubated in 25
were counter-stained with propidium iodide (Sigma, St. Louis, MO, USA)
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creased sub G1 population (Figure 2a) and also TUNEL
positive green colored cells as one of apoptosis features
in DU 145 prostate cancer cells (Figure 2b).Effect of EP on apoptosis related proteins in DU 145
prostate cancer cells
EP activated extrinsic apoptosis and attenuated survival
genes in DU 145 prostate cancer cells. EP activated cleaved
PARP, Bax and caspase 8/3, and attenuated the expression
of procaspase 8, Bcl-2, Bcl-XL without affecting procaspase
9 from the concentration of 25 μM compared to untreated
control in DU 145 prostate cancer cells as shown Figure 3a,
and b. We also confirmed that EP treatment attenuated
procaspase 8 and activated cleaved PARP and cleaved cas-
pase 3 in PC 3 cells (Figure 3c).Caspase 8 inhibitor Z-IETD-FMK and siRNA DR 5 blocked
the apoptotic ability of EP to cleave PARP
Caspase 8 inhibitor Z-IETD-FMK interrupted the cleav-
age of PARP induced by EP in DU 145 prostate cancer
cells (Figure 4a). Consistently, Z-IETD-FMK suppressed
sub G1 population up to 7.1% and 9.7%, respectively, at
the concentrations of 25 and 50 μM in EP treated DU
145 prostate cancer cells, while EP enhanced sub G1Figure 3 Effect of EP on PARP, procaspase 8/9, cleaved caspase 8/3, B
cells were treated with various concentrations of EP (0, 25, 50, 100, and 200
or β-actin antibodies to see apoptosis or survival related genes. (c) DU 145
carried out with PARP, procaspase 8, cleaved caspase 3 or β-actin antibodiepopulation up to 22.8% and 37.8% at the same concen-
trations in DU 145 prostate cancer cells (Figure 4b).
Apoptotic ability of EP via caspase 8, DR 5 in DU 145
prostate cancer cells
EP treated DU 145 enhanced the expression of FADD,
DR 5 and DR 4 while FLIP was attenuated (Figure 5a).
To confirm the roles of caspase 8 and DR 5 molecules
in EP induced apoptosis in DU 145 prostate cancer cells,
the silencing of DR 5 by siRNAs were used. As shown in
Figure 5b, siRNA transfection of DR 5 also blocked upreg-
ulation of DR 5 and cleavage of PARP and caspase 8 in-
duced by EP in DU 145 prostate cancer cells (Figure 5b)
indicating that DR 5 mediates EP induced apoptosis in
DU 145 cells.
Discussion
Neungyi mushrooms have been used as traditional medi-
cine or healthy food for years. Recent studies revealed the
multi-biological activities including immunomodulat-
ing, anti-inflammatory and anti-cancer effects of mush-
rooms such as Phellinus linteus, Sarcodon asparatus,
Ganoderma applanatum, Paecilomyces tenuipes and
Agaricus blazei [15-17].
Though ergosterol peroxide (EP) as a metabolite of
β-glucan, a well known antitumor component fromcl-2, Bcl-XL and Bax in DU 145 prostate cancer cells. (a, b) DU 145
μM) for 72 h and western blot was carried out with Bcl-xL, Bcl-2, Bax,
and PC 3 cells were treated with EP (25, 50 μM) and western blot was
s.
Figure 4 Effect of caspase 8 inhibitor Z-IETD-FMK on PARP in EP treated DU 145 prostate cancer cells. DU 145 cells were treated with EP
(25 or 50 μM) and/or caspase 8 inhibitor Z-IETD-FMK. Western blot assay (a) and FACS analysis (b) were performed.
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microbial, anti-tumor, anti-oxidative and immunosuppres-
sive effects, the underlying antitumor mechanism of EP
was not clearly understood in prostate cancer cells until
now. Thus, to determine the potential of EP as a cancer
chemopreventive agent or a dietary factor, in the current
study, the apoptotic mechanism of EP was elucidated
mainly in DU 145 prostate cancer cells.
EP showed the strong cytotoxic effect in the pros-
tate cancer cells lines such as DU 145, PC 3 or M2182
compared to other cancer cells in a concentration
dependent manner by MTT assay, implying its cyto-
toxic effect in prostate cancer cells. To confirm whether
the cytotoxicity was induced through apoptosis induc-
tion, cell cycle analysis using flow cytometry and
TUNEL assay was performed in DU 145 prostate can-
cer cells. EP significantly increased sub G1 population
and the number of TUNEL positive green colored cellsin DU 145 prostate cancer cells, indicating the apop-
totic feature of EP since apoptosis accompanies with
cell membrane wrinkled, DNA fragmentation, cytosol
calcium increased and form the apoptotic body in the
cells.
In general, there are two classical apoptotic pathways
including intrinsic mitochondrial pathway and extrinsic
death receptor pathway in cells [9]. In caspase-dependent
mitochondrial pathway, cytochrome c activates Apaf-1
and procaspase 9, forming an apoptosome [18,19]. In con-
trast, the extrinsic signaling pathways initiate apoptosis via
activation of caspase 8 and death receptors such as FasL/
FasR, TNF-α/TNFR 1, Apo3L/DR 3, Apo2L/DR 4 and
Apo2L/DR 5 [20], while death receptor-mediated apop-
tosis can be inhibited by a protein called c-FLIP which will
bind to FADD and caspase 8 [21,22]. Western blotting
showed that EP cleaved PARP and caspase 8/3 with-
out affecting caspase 9, attenuated the expression of
Figure 5 Effect of siRNA DR 5 transfection on PARP and procaspase 8 in EP treated DU 145 prostate cancer cells. (a) Western blot
assay was carried out with indicated antibodies to see the expression of FLIP, FADD, DR 5 or DR 4 in EP treated DU 145 cells. (b) After
transfection with siRNA DR 5, EP was treated and incubated in DU 145 cells for 24 h. The lysates were subjected to western blot analysis
using DR 5, PARP, procaspase 8 or β-actin antibodies. Bar graph represents the relative expression of the DR 5 protein by using images
J software.
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as well as activated the expression of proapoptotic pro-
tein Bax, FADD and DR 5 in a concentration dependent
manner in DU 145 prostate cancer cells, strongly dem-
onstrating death receptor dependent apoptosis by EP in
DU 145 prostate cancer cells.
Furthermore, to confirm EP induced extrinsic apop-
tosis, caspase 8 inhibitor Z-IETD-FMK and siRNA DR 5
transfection were used in inhibitor study for EP medi-
ated apoptosis. Z-IETD-FMK blocked the apoptotic abil-
ity of EP to cleave PARP and an increase of sub G1
population and the silencing of DR 5 suppressed the
cleavages of PARP induced by EP in DU 145 prostatecancer cells, indicating the death receptor dependent
apoptosis induced by EP.
Conclusions
In summary, EP showed significant cytotoxicity in DU 145
prostate cancer cells, increased sub G1 population and
TUNEL positive cells, activated the cleavages of PARP and
caspase 8/3 and Bax, FADD, and DR 5, but attenuated the
expression of survival genes such as c-FLIP, Bcl-XL and
Bcl-2 in DU 145 prostate cancer cells. Collectively, our
findings suggest that activation of death receptor 5 and
caspase 8/3 plays a key role in ergosterol peroxide induced
apoptosis in DU 145 prostate cancer cells.
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